Literature DB >> 7275184

The adjuvant activity of fatty acid esters. The role of acyl chain length and degree of saturation.

R Bomford.   

Abstract

Water-in-oil emulsions of metabolizable fatty acid esters, with the non-toxic surfactant Pluronic L122 as emulsifying agent, potentiated the humoral response to bovine serum albumin and staphylococcal toxoid in the mouse. Adjuvant activity was increased by changing the chemical nature of the esters as follows: (i) using a series of ethyl esters, adjuvant activity appeared when the acyl chain length of the fatty acid component was 16 or greater; (ii) isobutyl and isopropyl esters of palmitic acid (C16:0) were superior to ethyl; (iii) the ethyl esters of oleic (C18:1) and linoleic (C18:2) acids were better than stearic (C18:0). Since emulsions prepared with longer chain saturated esters are very viscous or solid at room temperature, and unsaturated esters are chemically reactive, emulsions were prepared with differing proportions of ethyl caprate (C10:0) and butyl stearate. At a ratio of 9:1 the emulsions possessed the low viscosity of ethyl caprate, but gained the adjuvant activity of butyl stearate. 125I-labelled BSA was retained in the footpad to a significantly greater extent than with a caprate emulsion, but reasons are given for believing that slow release of antigen is not the only mechanism of adjuvant activity. The ester emulsions caused more acute but less chronic local inflammation (footpad swelling) than Freund's incomplete adjuvant.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7275184      PMCID: PMC1555125     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

1.  Purification of staphylococcal alpha-toxin by adsorption chromatography on glass.

Authors:  P Cassidy; S Harshman
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

2.  The mechanism of the adjuvant effect of dextran sulphate.

Authors:  J W Bradfield; R L Souhami; I E Addison
Journal:  Immunology       Date:  1974-02       Impact factor: 7.397

3.  Cellular events in protein tolerant inbred rats. I. The fate of thoracic duct lymphocytes and memory cells during tolerance induction to human serum albumin.

Authors:  E B Bell; F L Shand
Journal:  Eur J Immunol       Date:  1973-05       Impact factor: 5.532

4.  A comparison of pluronic F-68, low molecular weight dextran, mannitol, and saline as priming agents in the heart-lung apparatus. II. The in vitro influence on oxygen consumption of certain fluids used as priming agents in a heart-lung bypass apparatus.

Authors:  A C Hymes; K Beck
Journal:  J Thorac Cardiovasc Surg       Date:  1968-07       Impact factor: 5.209

Review 5.  Critical appraisal of emulsified oil adjuvants applied to viral vaccines.

Authors:  M R Hilleman
Journal:  Prog Med Virol       Date:  1966

6.  Freund's adjuvants: relationship of arthritogenicity and adjuvanticity in rats to vehicle composition.

Authors:  M W Whitehouse; K J Orr; F W Beck; C M Pearson
Journal:  Immunology       Date:  1974-08       Impact factor: 7.397

7.  Antigenicity of soluble protein in the presence of high levels of antibody: a possible mode of action of the antigen adjuvants.

Authors:  W J Herbert
Journal:  Nature       Date:  1966-05-14       Impact factor: 49.962

8.  The adjuvant activity of aliphatic nitrogenous bases.

Authors:  D Gall
Journal:  Immunology       Date:  1966-10       Impact factor: 7.397

9.  Specific inhibitory action of polyunsaturated fatty acids on lymphocyte transformation induced by PHA and PPD.

Authors:  J Mertin; D Hughes
Journal:  Int Arch Allergy Appl Immunol       Date:  1975

10.  Adjuvant activity of a novel metabolizable lipid emulsion with inactivated viral vaccines.

Authors:  J A Reynolds; D G Harrington; C L Crabbs; C J Peters; N R Di Luzio
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

View more
  4 in total

1.  Enhancement of immunogenicity of tumour virus antigen by liposomes: the effect of lipid composition.

Authors:  O Bakouche; D Gerlier
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

Review 2.  Innate immunity and inflammation in systemic sclerosis.

Authors:  Robert Lafyatis; Michael York
Journal:  Curr Opin Rheumatol       Date:  2009-11       Impact factor: 5.006

3.  New insights into the mechanisms of innate immune receptor signalling in fibrosis.

Authors:  Robert Lafyatis; Alessandra Farina
Journal:  Open Rheumatol J       Date:  2012-06-15

Review 4.  Immunostimulation by synthetic lipopeptide-based vaccine candidates: structure-activity relationships.

Authors:  Mehfuz Zaman; Istvan Toth
Journal:  Front Immunol       Date:  2013-10-09       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.